I-Mab Ownership | Who Owns I-Mab?
I-Mab Ownership Summary
I-Mab is owned by 17.08% institutional investors, 11.16% insiders, and 71.76% retail investors. Hhlr advisors is the largest institutional shareholder, holding 7.79% of IMAB shares. abrdn Healthcare Investors is the top mutual fund, with 0.07% of its assets in I-Mab shares.
IMAB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | I-Mab | 17.08% | 11.16% | 71.76% |
| Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
| Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Hhlr advisors | 6.91M | 7.79% | $11.54M |
| Caligan partners lp | 3.37M | 3.81% | $5.64M |
| Boothbay fund management | 1.38M | 1.56% | $2.30M |
| Two sigma advisers, lp | 576.60K | 0.65% | $962.92K |
| Temasek (private) | 566.65K | 0.64% | $946.31K |
| Two sigma investments, lp | 478.44K | 0.54% | $799.00K |
| Edbi pte | 222.14K | 0.25% | $370.97K |
| Abrdn | 162.58K | 0.18% | $271.51K |
| State street | 102.96K | 0.12% | $171.94K |
| Alberta investment management | 74.72K | 0.08% | $124.79K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Caligan partners lp | 3.37M | 1.32% | $5.64M |
| Edbi pte | 222.14K | 0.42% | $370.97K |
| Hhlr advisors | 6.91M | 0.28% | $11.54M |
| Boothbay fund management | 1.38M | 0.05% | $2.30M |
| Temasek (private) | 566.65K | 0.00% | $946.31K |
| Xtx topco | 17.88K | 0.00% | $29.85K |
| Two sigma advisers, lp | 576.60K | 0.00% | $962.92K |
| Two sigma investments, lp | 478.44K | 0.00% | $799.00K |
| Alberta investment management | 74.72K | 0.00% | $124.79K |
| Abrdn | 162.58K | 0.00% | $271.51K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Caligan partners lp | 3.37M | 1.32% | 2.62M |
| Boothbay fund management | 1.38M | 0.05% | 1.00M |
| Susquehanna group, llp | 31.07K | - | 31.07K |
| Ubs group | 12.51K | - | 11.18K |
| Morgan stanley | 13.88K | - | 3.77K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Gsa capital partners llp | - | - | -272.19K |
| Exome asset management | - | - | -271.40K |
| Bank of montreal /can/ | - | - | -244.88K |
| Man group | - | - | -134.98K |
| Two sigma investments, lp | 478.44K | 0.00% | -97.14K |
Sold Out
| Holder | Change |
|---|---|
| Frazier financial advisors | -515.00 |
| Royal bank of canada | -1.64K |
| Qube research | -2.56K |
| Marshall wace, llp | -14.06K |
| Atom investors lp | -29.61K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 37 | -5.13% | 15,140,372 | 25.67% | 17 | 8.14% | 8 | -46.67% | 16 | 60.00% |
| Mar 31, 2024 | 39 | -13.33% | 12,048,189 | -2.39% | 14 | 5.49% | 15 | -28.57% | 10 | -28.57% |
| Dec 31, 2023 | 45 | -8.16% | 12,343,395 | -36.43% | 16 | 2.49% | 21 | -8.70% | 14 | - |
| Sep 30, 2023 | 49 | 2.08% | 19,417,896 | 3.89% | 25 | 4.22% | 23 | 43.75% | 14 | -17.65% |
| Jun 30, 2023 | 48 | -11.11% | 18,691,045 | -9.71% | 24 | 20697272.48% | 16 | - | 17 | -29.17% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| abrdn Healthcare Investors | 53.88K | 0.07% | - |
| abrdn Healthcare Opportunities | 43.74K | 0.06% | - |
| abrdn World Healthcare | 38.85K | 0.05% | - |
| abrdn Life Sciences Investors | 26.11K | 0.03% | - |
| Fidelity Nasdaq Composite Index | 22.04K | 0.03% | - |
| DFA Emerging Markets Social Core Port | 18.91K | 0.02% | - |
| Dimensional Emerg Mkt Trgtd Val USD Acc | 14.50K | 0.02% | - |
| DFA Em Mkts Sustnby Cor 1 Instl | 9.31K | 0.01% | - |
| Blackstone Alternative Multi-Strategy I | 8.80K | 0.01% | -900.00 |
| VL China Fund B | 6.20K | 0.01% | 6.20K |
IMAB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools